-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UzBHokgp7GwEEakJTwFm0lMV/6VzYdmlGUSpjfAZd9DwthHQoOqd2+iOahBX2ZpH k7cniJVigJvmQ1pqxEuMUA== 0001381825-09-000004.txt : 20090420 0001381825-09-000004.hdr.sgml : 20090420 20090417190107 ACCESSION NUMBER: 0001381825-09-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090420 DATE AS OF CHANGE: 20090417 EFFECTIVENESS DATE: 20090420 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CELL BIOSCIENCES INC CENTRAL INDEX KEY: 0001381825 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-96789 FILM NUMBER: 09757873 BUSINESS ADDRESS: STREET 1: 1050 PAGE MILL RD CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 650 859 1485 MAIL ADDRESS: STREET 1: 1050 PAGE MILL RD CITY: PALO ALTO STATE: CA ZIP: 94304 D 1 primary_doc.xml X0301 D LIVE 0001381825 CELL BIOSCIENCES INC 1050 PAGE MILL RD PALO ALTO CA 94304 650 859 1485 None DE Corporation true Timothy Harkness c/o Cell Biosciences, Inc. 1050 Page Mill Road Palo Alto CA 94304 Executive Officer Director David Barker c/o Cell Biosciences, Inc. 1050 Page Mill Road Palo Alto CA 94304 Director James Blair c/o Domain Associates One Palmer Square, Suite 515 Princeton NJ 08542 Director A. Blaine Bowman c/o Cell Biosciences, Inc. 1050 Page Mill Road Palo Alto CA 94304 Director Julie Eskay-Eagle c/o The Wellcome Trust Gildos Building, 215 Euston Road London X0 NW1 2BE Director Jack Nielson c/o Novo A/S Krogshoejvej 41 Bagsvaerd G7 DK 2880 Director James Woody c/o Latterell Venture Partners 1 Embarcadero Center, Suite 4050 San Francisco CA 94111 Director James Novi c/o Cell Biosciences, Inc. 1050 Page Mill Road Palo Alto CA 94304 Executive Officer Biotechnology Decline to Disclose 06 false 2009-04-09 false true true Offering of Series C Preferred Stock (the "Series C") and the underlying shares of Common Stock issuable upon conversion of the Series C. false 0 10592611 5000004 5592607 false 11 0 0 0 false CELL BIOSCIENCES INC /s/ Timothy Harkness Timothy Harkness President and CEO 2009-04-16 -----END PRIVACY-ENHANCED MESSAGE-----